2009 Midyear Clinical Meeting
Click here to go to the previous page
Pharmaceutical Waste - Connect Four!
Track:
Educational Sessions (CE)
Program Code: 265-L03
Date: Wednesday, December 9, 2009
Time: 8:00 AM to 9:45 AM EST
Location:
3201A - Murano
MEETING PLANNING ASSOCIATE:
Click the plus sign to see more detailed information about each speaker.
Thomas Kirschling,
PharmD, MS, Manager, Pharmacy Operations,
University of Pittsburgh Medical Center
|
Thomas E. Kirschling is Manager of Pharmacy Operations at University of Pittsburgh Medical Center (UPMC) and Adjunct Instructor for the University of Pittsburgh School of Pharmacy. In addition to operational oversight of central and operating room pharmacies at UPMC Presbyterian, he oversees quality improvement programs, storage and security of medication including responsibility for controlled substances, and optimization of automation and workflow. He completed a combined residency with Masters of Science degree in Health-System Pharmacy Administration following completion of his Doctor of Pharmacy at the University of Wisconsin, completed Six Sigma Green Belt training from Motorola University, and is currently pursing a Master of Studies degree in Law from the University of Pittsburgh. In addition to commitments to state national and state organizations, he is dedicated to the teaching and mentoring of both students and residents.
|
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
Mark Caverly, Chief, Liaison and Policy Section, Office of Diversion Control,
Drug Enforcement Administration
|
Mark Caverly is Chief of the Liaison and Policy Section in the Office of Diversion Control, Drug Enforcement Administration (DEA). Mark is a Senior Diversion Investigator and has served with DEA for 29 years.
The DEA Office of Diversion Control enforces the provisions of the Controlled Substances Act that pertain to legally produced controlled substances and listed chemicals. Its mission is to prevent, detect, and investigate the diversion of legitimate controlled substances and listed chemicals while ensuring an adequate supply for legitimate medical, scientific, and industrial needs.
Mr. Caverly oversees three units within the Liaison and Policy Section that serve as primary point of contact to the pharmaceutical, chemical, and medical communities; implement federal law through the drafting of regulations; and interpret agency policy to regulated companies and persons. DEA monitors more than 1.3 million registrants through an active system of regulations, recordkeeping, reporting, and security requirements.
Mr. Caverly has served as a Diversion Investigator in Miami, Florida; Boston, Massachusetts; and Louisville, Kentucky. He has been a field supervisor, a staff coordinator in the International Chemical Unit, a staff coordinator in the DEA Deputy Administrators office, a section chief at the Special Operations Division, and a section chief of the Liaison and Policy Section.
|
Christian Daughton,
PhD, BA, Chief, Environmental Chemistry Branch,
U.S. Environmental Protection Agency
|
Dr. Christian Daughton's research at the U.S. Environmental Protection Agency's Office of Research and Development Laboratory (Las Vegas, Nevada) focuses on the environmental ramifications of non-regulated chemical pollutants (http://epa.gov/nerlesd1/bios/daughton.htm). He pioneered EPA's involvement with pharmaceuticals and personal care products (PPCPs) in the late 1990s. Prior to joining the EPA in 1991, he was research toxicology faculty at U.C. Berkeley and a supervisory research scientist at Lawrence Berkeley Laboratory. He earned a B.A. in biology at the University of California, San Diego (Revelle College), and a Ph.D. in ecology from the Department of Environmental Toxicology at University of California, Davis. He performed postdoctoral research at Cornell University on microbial degradation of organophosphorus insecticides and chemical warfare agents.
|
Lindsey Kelley,
PharmD, MS, Manager, Pharmacy Operations,
UPMC Presbyterian Shadyside
|
Lindsey R. Kelley, Pharm.D., M.S., is a graduate of the University of Arizona College of Pharmacy. She completed a PGY-1 Pharmacy Practice Residency at Abbott Northwestern Hospital and a two-year specialty residency and Masters in Social, Administrative, and Clinical Pharmacy at the University of Minnesota Medical Center, Fairview; both in Minneapolis, MN. She recently moved to Pennsylvania where she serves as a Manager of Pharmacy Operations at the University of Pittsburgh Medical Center (UPMC) Presbyterian Shadyside. She recently served as the Chair of the American Society of Health-System Pharmacists (ASHP) New Practitioner Forum Executive Committee as well as liaison to the New Practitioner Forum Professional Practice Affairs Advisory Group. She is a member of the ASHP Section Advisory Group on Manager Development and the ASHP Membership Development Advisory Group.
|
Thomas Kirschling,
PharmD, MS, Manager, Pharmacy Operations,
University of Pittsburgh Medical Center
|
Thomas E. Kirschling is Manager of Pharmacy Operations at University of Pittsburgh Medical Center (UPMC) and Adjunct Instructor for the University of Pittsburgh School of Pharmacy. In addition to operational oversight of central and operating room pharmacies at UPMC Presbyterian, he oversees quality improvement programs, storage and security of medication including responsibility for controlled substances, and optimization of automation and workflow. He completed a combined residency with Masters of Science degree in Health-System Pharmacy Administration following completion of his Doctor of Pharmacy at the University of Wisconsin, completed Six Sigma Green Belt training from Motorola University, and is currently pursing a Master of Studies degree in Law from the University of Pittsburgh. In addition to commitments to state national and state organizations, he is dedicated to the teaching and mentoring of both students and residents.
|
Firouzan Fred Massoomi, Pharm.D., FASHP, received his Doctor of Pharmacy Degree from the University of Kansas School of Pharmacy, Lawrence, Kansas, 1990. His post-doctoral education included the completion 1 year of a 2 year ACCP-Accredited Fellowship in Infectious Diseases and Pharmacokinetics at the Universite Laval Laboratoire de Pharmacocinetique in Quebec City Quebec Canada 1991; completed an ACCP-Accredited Residency in Clinical Pharmacokinetics at Saint Joseph Hospital & Creighton University School of Pharmacy and Allied Health Professionals, Omaha, Nebraska in 1992. His current position is acting Pharmacy Operations Coordinator with the Department of Pharmacy at Nebraska Methodist Hospital in Omaha, Nebraska. A position he has held since 1996.
Dr. Massoomi has lectured nationally on implementation strategies for compliance with USP <797>, proper hazardous drug management as outlined in the Centers for Disease Controls National Institute of Occupational Safety and Health Alert, and, proper disposal of hazardous drug waste as outlined by the Environmental Protection Agencys Resource and Conservation Act of 1976.
|
Katie McMillen,
PharmD, MPH, Pharmacy Operations Manager,
University of Pittsburgh Medical Center
|
Katie is from Pittsburgh, PA, and received her PharmD from the University of Pittsburgh in 2005 and Master in Public Health in 2008. She worked as an intern and pharmacist at UPMC Western Psychiatric Institute & Clinic prior to completing a Pharmacy Practice Management residency at UPMC Presbyterian-Shadyside where she stayed on upon graduation to work as a Pharmacy Operations Manager.
|
Charlotte Smith,
RPh, MS, Director,
Waste Management Healthcare Solutions, PharmEcology Services
Charlotte Smith is Director of PharmEcology Services, part of Waste Management Healthcare Solutions (WMHS). She founded PharmEcology Associates, LLC in 2000 and sold the company to WMHS in April of 2009. Being a part of WMHS will enable PharmEcology to assist the healthcare industry in reducing and managing pharmaceutical waste even more effectively. She co-founded Capital Returns, Inc., a nationally known pharmaceutical reverse distributor in 1991 and for 10 years served as president and chief regulatory advisor. Ms. Smith is a registered pharmacist who received her BS in Pharmacy and MS in Continuing and Vocational Education from the University of Wisconsin. She is a member of the Pharmacy Society of Wisconsin, the American Society of Health-System Pharmacists, and the American Society for Healthcare Environmental Services. She can be reached at 414-292-3959 or at csmith@pharmecology.com.
|
Description
Planned in cooperation with the ASHP Section of Pharmacy Practice Managers
ACPE Activity #204-000-09-265-L03P
1.75 Contact Hours / Knowledge-based
Educational Content: General Interest
Moderator: Thomas E. Kirschling, PharmD, MS, Manager, Pharmacy Operations, University of Pittsburgh Medical Center, Pittsburgh, PA
8:00 a.m. – 8:05 a.m.
Announcements
8:05 a.m. – 8:20 a.m.
Environmental Contaminants: An Overview of the Science
Christian Daughton, PhD, BA, Chief, Environmental Chemistry Branch, U.S. Environmental Protection Agency, Las Vegas, NV
8:20 a.m. – 8:40 a.m.
EPA Perspective and Regulations
Charlotte Smith, RPh, MS, Director, Waste Management Healthcare Solutions, PharmEcology Services, Wauwatosa, WI
8:40 a.m. – 9:05 a.m.
DEA Perspective and Regulations
Mark W. Caverly, Chief, Liaison and Policy Section, Office of Diversion Control, Drug Enforcement Administration, Springfield, VA
9:05 a.m. – 9:30 a.m.
Employer Perspective
Firouzan "Fred" Massoomi, PharmD, FASHP, Pharmacy Operations Coordinator, Nebraska Methodist Hospital, Omaha
9:30 a.m. – 9:40 a.m.
Employee Perspective and OSHA
Katie McMillen, PharmD, MPH, Pharmacy Operations Manager, University of Pittsburgh Medical Center, Pittsburgh, PA
Lindsey R. Kelley, PharmD, MS, Manager, Pharmacy Operations, UPMC Presbyterian Shadyside, Pittsburgh, PA
9:40 a.m. – 9:45 a.m.
Questions, Answers, and Discussion
Learning Objectives:
LEARNER OUTCOMES:
- Describe success stories and common pitfalls.
- Explain how to perform a gap analysis with your institution's pharmaceutical waste handling practice, and identify individuals needed within the institution to close any gaps.
- Identify congruent and incongruent aspects of four perspectives on handling pharmaceutical waste.
- List factors that are changing the face of pharmaceutical waste handling.
- Name several new and existing pharmaceutical waste management tools and services.
